BAFNA PHARMACEUTICALS
|
The Current P/S Ratio of BAFNA PHARMACEUTICALS is 2.32.
| Share Price | ₹147.5 | Jun 02,2026 |
| Market Cap | ₹349.5 Cr | |
| Sales-TTM | ₹150.6 Cr | TTM-Standalone Results |
| Price/Sales | 2.32x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of BAFNA PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹349.5 Cr] as on Jun 02,2026
(/) Sales [ ₹150.6 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 2.32x ]
Thus, for BAFNA PHARMACEUTICALS , the investors are currently willing to pay '2.32 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of BAFNA PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of BAFNA PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of BAFNA PHARMACEUTICALS
PS Ratio Performance Analysis for BAFNA PHARMACEUTICALS
- BAFNA PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 2.44x.
- BAFNA PHARMACEUTICALS 's operated at median p/e ratio of 1.7x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BAFNA PHARMACEUTICALS 's p/e ratio peaked in Mar2021 at 4.56x.
- BAFNA PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2024 of 1.19x.
How does BAFNA PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| BAFNA PHARMACEUTICALS | 150.6 | 2.32 | 349.5 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 58,462.0 | 7.35 | 429,469.0 |
| DIVIS LABORATORIES LTD | 10,560.0 | 16.41 | 173,305.0 |
| TORRENT PHARMACEUTICALS LTD | 13,980.0 | 10.44 | 146,014.0 |
| CIPLA LTD | 28,162.6 | 3.96 | 111,388.0 |
| DR REDDYS LABORATORIES LTD | 33,700.2 | 3.16 | 106,381.0 |
| MANKIND PHARMA LTD | 14,277.6 | 6.65 | 94,907.2 |
| LUPIN LTD | 27,958.0 | 3.68 | 102,853.0 |
| ZYDUS LIFESCIENCES LTD | 27,148.4 | 3.99 | 108,397.0 |
| AUROBINDO PHARMA LTD | 33,653.1 | 2.44 | 82,241.6 |
| LAURUS LABS LTD | 6,812.9 | 10.96 | 74,673.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs BAFNA PHARMACEUTICALS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.32x |
| Max industry PS | 16.41x |
| Median industry PS | 3.99x |
| Average industry PS | 6.49x |
You may also like the below Video Courses